Welcome to LookChem.com Sign In|Join Free
  • or
C23H29NO6S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1146970-01-5

Post Buying Request

1146970-01-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1146970-01-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1146970-01-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,6,9,7 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1146970-01:
(9*1)+(8*1)+(7*4)+(6*6)+(5*9)+(4*7)+(3*0)+(2*0)+(1*1)=155
155 % 10 = 5
So 1146970-01-5 is a valid CAS Registry Number.

1146970-01-5Relevant academic research and scientific papers

Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors

Xu, Wenjian,Gray, David L.,Glase, Shelly A.,Barta, Nancy S.

scheme or table, p. 5550 - 5553 (2009/05/30)

As part of a discovery effort aimed at identifying novel norepinephrine reuptake inhibitors (NRIs), a number of substituted morpholines were designed and synthesized. The target compounds contain vicinal stereogenic centers, and the program was greatly facilitated by the adoption of efficient synthetic routes which allowed for the late stage incorporation of structural and physicochemical diversity into the targets. Structure-activity relationships were developed by optimizing individual ring components of the structure for NRI potency and for selectivity against other monoamine reuptake transporters. Several novel morpholine derivatives with a potent and selective NRI profile are described.

Substituted morpholine compounds for the treatment of central nervous system disorders

-

Page/Page column 45, (2010/02/14)

This invention relates to compounds of the formulae I wherein R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1146970-01-5